Scholar Rock
SRRK----
Scholar Rock (SRRK)
Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on improving the lives of children and adults with spinal muscular atrophy (SMA) and othe...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
Scholar Rock Analyst Rating
View MoreForecast & Rating
Jul 23, 2026Price forecast
$59.3124.42%
Forecast & RatingStrong buy
18analysts
- Strong buy83.33%
- Buy16.67%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- Market Beat · Jul 21 at 09:18 AM
Scholar Rock (NASDAQ:SRRK) Receives Outperform Rating from Wedbush
- PUBT · Jul 20 at 07:05 AM
Scholar Rock announces press release on apitegromab CHMP opinion timing for SMA MAA
- Tip Ranks · Jul 17 at 07:55 AM
Leerink Partners Reaffirms Their Buy Rating on Scholar Rock Holding (SRRK)
- PUBT · Jul 16 at 07:00 AM
Scholar Rock to report Q2 2026 financial results, host conference call
- rttnews · Jul 13 at 06:18 AM
Biotech Stocks At 52-Week Highs: AMWL, CUE, ICCC, SRRK, FTH
- TradingView · Jul 7 at 11:20 PM
Scholar Rock Holding Corporation Stock 12‑Month Price Target Raised to $60.07, Implies 6% Upside
